CML-129: OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses of Ponatinib (PON)
Year: 2021
Type: conference-abstract
Authors: Jorge E. Cortes, Jane F. Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues De Lavallade, Michael J. Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael W. Deininger
Institutions: The University of Texas MD Anderson Cancer Center, Augusta University, Imperial College Healthcare NHS Trust, Federal Almazov North-West Medical Research Centre, Hospital Ramos Mejía, Hospital del Salvador, Singapore General Hospital, Duke-NUS Medical School, Jagiellonian University, Szpital Uniwersytecki w Krakowie, University of Toronto, Hackensack Meridian Health, Jena University Hospital, Université de Versailles Saint-Quentin-en-Yvelines, King's College Hospital NHS Foundation Trust, King's College Hospital, Memorial Sloan Kettering Cancer Center, Takeda Oncology (United States), University of Utah, Huntsman Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3197319859